Results 101 to 110 of about 1,001 (176)

Baseline cell cycle and immune profiles indicate CDK4/6 inhibitor response in metastatic HR + /HER2- breast cancer. [PDF]

open access: yesNPJ Breast Cancer
Tzetzo SL   +6 more
europepmc   +1 more source

Prognostic immune markers in esophageal cancer patients managed with trimodal therapy. [PDF]

open access: yesCancer Immunol Immunother
Farrugia MK   +11 more
europepmc   +1 more source

Targeting FGFR4 abrogates HNF1A-driven metastasis in pancreatic ductal adenocarcinoma. [PDF]

open access: yesMol Cancer
Crawford KJ   +11 more
europepmc   +1 more source

NC410, a bivalent LAIR-2 construct, remodels collagen in the tumor microenvironment and abrogates neutrophil-driven T cell suppression. [PDF]

open access: yesJ Immunol
Giridharan T   +20 more
europepmc   +1 more source

Cardiac sarcoidosis — diagnostic difficulties

open access: yesNuclear Medicine Review
Małgorzata Poniatowska-Roszkowska   +5 more
doaj   +1 more source

Perinatal Outcomes and Level of Labour Difficulty in Deliveries with Right and Left Foetal Position-A Preliminary Study. [PDF]

open access: yesHealthcare (Basel)
Witkiewicz M   +10 more
europepmc   +1 more source

BRCA1/2 and Other Predisposition Genes in High-Risk Hormone Receptor+/Human Epidermal Growth Factor Receptor 2- Breast Cancer Treated With Endocrine Therapy With or Without Palbociclib: A Secondary PENELOPE-B Study Analysis. [PDF]

open access: yesJCO Precis Oncol
Hahnen E   +37 more
europepmc   +1 more source

Three-Layered Composite Scintillator Based on the Epitaxial Structures of YAG and LuAG Garnets Doped with Ce3+ and Sc3+ Impurities. [PDF]

open access: yesMaterials (Basel)
Witkiewicz-Łukaszek S   +11 more
europepmc   +1 more source

Real-World Experience among Elderly Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitor-Based Therapy. [PDF]

open access: yesCancers (Basel)
O'Connor TN   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy